An invasive GBM phenotype is characterized by high ability of cancer cells to degrade and migrate through the ECM, which is associated with the activity of matrix metalloproteinases MMP-2 and MMP-9, responsible for the ECM remodeling [50,51,52]. Here, MMP9 is linked to glioblastoma.